Christopher Brown
Directeur Général chez WellSpring Pharmaceutical Corp.
Profil
Christopher Brown currently works at WellSpring Pharmaceutical Corp., as Chief Executive Officer from 2022.
Postes actifs de Christopher Brown
| Sociétés | Poste | Début |
|---|---|---|
WellSpring Pharmaceutical Corp.
 WellSpring Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology WellSpring Pharmaceutical Corp. develops and distributes cardiovascular and pharmaceutical products including bonine, emitrol and gelusil. It offers search and develop approach to pharmaceuticals, bringing much-needed prescription medications to little-known illnesses. The firm’s products include bonine, emetrol, gelusil, micatin, bactine and FDS. The company was founded by Robert A. Vukovich and Wendy M. Shusko in 1999 and is headquartered in Sarasota, FL. | Directeur Général | 01/01/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
WellSpring Pharmaceutical Corp.
WellSpring Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology WellSpring Pharmaceutical Corp. develops and distributes cardiovascular and pharmaceutical products including bonine, emitrol and gelusil. It offers search and develop approach to pharmaceuticals, bringing much-needed prescription medications to little-known illnesses. The firm’s products include bonine, emetrol, gelusil, micatin, bactine and FDS. The company was founded by Robert A. Vukovich and Wendy M. Shusko in 1999 and is headquartered in Sarasota, FL. | Health Technology |
